Sign Up

CTNM

COM:CONTINEUM-TX

Contineum Therapeutics

  • Stock

USD

Last Close

7.69

14/02 21:00

Market Cap

541.73M

Beta: -

Volume Today

47.20K

Avg: -

OverviewMetricsFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
revenue
50M
-
cost of revenue
329K
-
195K
40.73%
gross profit
-329K
-
49.80M
15,238.30%
selling and marketing expenses
-329K
-
-195K
40.73%
general and administrative expenses
6.29M
-
5.83M
7.33%
6.32M
8.48%
selling general and administrative expenses
6.29M
-
5.50M
12.57%
6.13M
11.42%
research and development expenses
22.36M
-
16.89M
24.45%
27.60M
63.39%
other expenses
-91K
-
-92K
1.10%
-177K
92.39%
cost and expenses
28.65M
-
22.72M
20.69%
33.92M
49.31%
operating expenses
28.65M
-
22.39M
21.84%
33.73M
50.63%
interest expense
332K
-
388K
16.87%
208K
46.39%
ebitda
-28.34M
-
-22.39M
20.98%
16.27M
172.67%
operating income
-28.65M
-
-22.72M
20.69%
16.08M
170.76%
depreciation and amortization
325K
-
329K
1.23%
195K
40.73%
total other income expenses net
-99K
-
-1.53M
1,448.48%
7.09M
562.69%
income before tax
-29.00M
-
-24.25M
16.37%
23.17M
195.53%
income tax expense
241K
-
450K
-
net income
-29.00M
-
-24.25M
16.37%
22.72M
193.68%
weighted average shs out
16.67M
-
25.13M
50.72%
25.13M
0%
weighted average shs out dil
17.76M
-
25.13M
41.50%
25.13M
0%
eps
-1.74
-
-0.97
44.25%
0.13
113.40%
epsdiluted
-1.63
-
-0.97
40.49%
0.13
113.40%

All numbers in USD (except ratios and percentages)